Innovative Research Award
Manuel Muñoz Torres
Universidad De Granada
The Innovative Research Award recognizes researchers whose scholarly contributions demonstrate sustained scientific excellence, interdisciplinary collaboration, and measurable impact on advancing diagnostic science and healthcare research. Manuel Muñoz Torres has established a significant academic record through extensive publications, influential citations, and continued participation in internationally recognized research initiatives.[1]
Abstract
Manuel Muñoz Torres is a distinguished academic affiliated with Universidad De Granada whose research has significantly contributed to diagnostic science and related biomedical disciplines. His scholarly portfolio comprises 299 indexed publications supported by more than 6,800 citations and an h-index of 43, reflecting sustained scientific influence across international research communities. His work emphasizes evidence-based clinical investigation, multidisciplinary collaboration, and the advancement of diagnostic methodologies that improve patient care and medical decision-making. These achievements demonstrate research excellence, academic leadership, and continuous knowledge dissemination, making his profile highly relevant for recognition through the Global Diseases Research Awards.[1]
Keywords
Innovative Research Award, Diagnostic Research, Clinical Investigation, Biomedical Science, Medical Diagnostics, Translational Medicine, Scientific Publications, Research Excellence, Global Diseases Research Awards, Healthcare Innovation.
Introduction
Diagnostic research plays an essential role in improving disease detection, treatment strategies, and healthcare outcomes through evidence-based scientific investigation. Researchers who consistently contribute validated findings and collaborative innovation strengthen both clinical practice and biomedical knowledge, supporting international progress in disease management and medical research.[2]
Research Profile
Manuel Muñoz Torres has developed an internationally recognized academic profile through sustained publication activity, interdisciplinary collaboration, and contributions to diagnostic medicine. His Scopus-indexed research output, citation performance, and h-index collectively indicate consistent scholarly productivity and continuing influence across biomedical research communities.[1]
Research Contributions
His scientific contributions encompass diagnostic methodologies, clinical evaluation, translational medicine, and collaborative healthcare research. Through peer-reviewed investigations, he has supported the development of improved diagnostic understanding while promoting evidence-based medical practices that benefit both researchers and healthcare professionals worldwide.[3]
Publications
The researcher’s publication portfolio includes 299 scholarly documents indexed in Scopus across diagnostic and biomedical disciplines. These publications demonstrate continuous scientific productivity and have received substantial international recognition through citations, reflecting both academic relevance and sustained research quality.[4]
Research Impact
An h-index of 43 together with 6,813 citations illustrates meaningful scholarly influence within diagnostic research. Citation performance suggests that numerous publications have contributed to subsequent scientific investigations, reinforcing the researcher’s role in advancing biomedical knowledge and encouraging continued international collaboration.[5]
Award Suitability
Based on measurable scholarly indicators, extensive publication activity, and sustained research influence, Manuel Muñoz Torres demonstrates characteristics consistent with the objectives of the Innovative Research Award. His academic achievements align with the recognition of impactful research, scientific excellence, and contributions supporting diagnostic advancement.[4]
Conclusion
The available bibliometric evidence highlights a distinguished academic career characterized by consistent productivity, significant citation impact, and meaningful contributions to diagnostic science. These accomplishments reflect a sustained commitment to scientific excellence and justify consideration within international academic recognition programs.[1]
External Links
References
- Elsevier. (n.d.). Scopus author details: Manuel Muñoz Torres, Author ID 7006824938. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=7006824938
- Global Diseases Research Awards. (2026). Innovative Research Award.
https://globaldiseases.org/
- Pols, H. A., Felsenberg, D., Hanley, D. A., Stepán, J., Muñoz-Torres, M., Wilkin, T. J., Qin-sheng, G., Galich, A. M., Vandormael, K., Yates, A. J., & Stych, B. (1999). Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: Results of the FOSIT study. Osteoporosis International, 9(5), 461–468.
https://doi.org/10.1007/PL00004171
- Garber, A. J., King, A. B., Del Prato, S., Sreenan, S., Balci, M. K., Muñoz-Torres, M., Rosenstock, J., Endahl, L. A., Ocampo Francisco, A. M., Hollander, P., & NN1250-3582 (BEGIN BB T2D) Trial Investigators. (2012). Insulin degludec, an ultra-long-acting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): A phase 3, randomised, open-label, treat-to-target non-inferiority trial. The Lancet, 379(9825), 1498–1507.
https://doi.org/10.1016/S0140-6736(12)60205-0
- García-Martín, A., Rozas-Moreno, P., Reyes-García, R., Morales-Santana, S., García-Fontana, B., García-Salcedo, J. A., & Muñoz-Torres, M. (2012). Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus. The Journal of Clinical Endocrinology & Metabolism, 97(1), 234–241.
https://doi.org/10.1210/jc.2011-2186